JN AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 101: 1179-1191, 2009. First published December 10, 2008; doi:10.1152/jn.91203.2008
0022-3077/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/3/1179    most recent
91203.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zarnowska, E. D.
Right arrow Articles by Pearce, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zarnowska, E. D.
Right arrow Articles by Pearce, R. A.

GABAA Receptor {alpha}5 Subunits Contribute to GABAA,slow Synaptic Inhibition in Mouse Hippocampus

Ewa D. Zarnowska1, Ruth Keist2, Uwe Rudolph2,3 and Robert A. Pearce1

1Department of Anesthesiology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; 2Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland; and 3Laboratory of Genetic Neuropharmacology, McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, Massachusetts

Submitted 10 November 2008; accepted in final form 5 December 2008

Abstract

{gamma}-Aminobutyric acid type A (GABAA) receptor {alpha}5 subunits, which are heavily expressed in the hippocampus, are potential drug targets for improving cognitive function. They are found at synaptic and extrasynaptic sites and have been shown to mediate tonic inhibition in pyramidal neurons. We tested the hypothesis that {alpha}5 subunits also contribute to synaptic inhibition by measuring the effect of diazepam (DZ) on spontaneous and stimulus-evoked inhibitory postsynaptic currents (IPSCs) in genetically modified mice carrying a point mutation in the {alpha}5 subunit ({alpha}5-H105R) that renders those receptors insensitive to benzodiazepines. In wild type mice, DZ (1 µM) increased the amplitude of spontaneous IPSCs (sIPSCs) and stimulus-evoked GABAA,slow IPSCs (eIPSCs) and prolonged the decay of GABAA,fast sIPSCs. In {alpha}5-mutant mice, DZ increased the amplitude of a small-amplitude subset of sIPSCs (<50 pA) and eIPSCs (<300 pA) GABAA,slow and prolonged the decay of GABAA,fast sIPSCs, but failed to increase the amplitude of larger sIPSCs and eIPSCs GABAA,slow. These results indicate that {alpha}5 subunits contribute to a large-amplitude subset of GABAA,slow synapses and implicate these synapses in modulation of cognitive function by drugs that target {alpha}5 subunits.


Address for reprint requests and other correspondence: E. D. Zarnowska, Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, 601 Science Dr., Madison, WI 53711 (E-mail: edzarnowska{at}wisc.edu) or R. A. Pearce (E-mail: rapearce{at}wisc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the The American Physiological Society.